Literature DB >> 6801090

Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis.

E M Kaptein, W J Robinson, D A Grieb, J T Nicoloff.   

Abstract

The low thyroxine (T(4)) state of acute critical nonthyroidal illnesses is characterized by marked decreases in serum total T(4) and triiodothyronine (T(3)) with elevated reverse T(3) (rT(3)) values. To better define the mechanisms responsible for these alterations, serum kinetic disappearance studies of labeled T(4), T(3), or rT(3) were determined in 16 patients with the low T(4) state and compared with 27 euthyroid controls and a single subject with near absence of thyroxine-binding globulin. Marked increases in the serum free fractions of T(4) (0.070+/-0.007%, normal [nl] 0.0315+/-0.0014, P < 0.001), T(3) (0.696+/-0.065%, nl 0.310+/-0.034, P < 0.001), and rT(3) (0.404+/-0.051%, nl 0.133+/-0.007, P < 0.001) by equilibrium dialysis were observed indicating impaired serum binding. Noncompartmental analysis of the kinetic data revealed an increased metabolic clearance rate (MCR) of T(4) (1.69+/-0.22 liter/d per m(2), nl 0.73+/-0.05, P < 0.001) and fractional catabolic rate (FCR) (32.8+/-2.6%, nl 12.0+/-0.8, P < 0.001), analogous to the euthyroid subject with low thyroxine-binding globulin. However, the reduced rate of T(4) exit from the serum (Kii) (15.2+/-4.6 d(-1), nl 28.4+/-3.9, P < 0.001) indicated an impairment of extravascular T(4) binding that exceeded the serum binding defect. This defect did not apparently reduce the availability of T(4) to sites of disposal as reflected by the increased fractional disposal rate of T(4) (0.101+/-0.018 d(-1), nl 0.021+/-0.003, P < 0.001). The decreased serum T(3) binding was associated with the expected increases in MCR (18.80+/-2.22 liter/d per m(2), nl 13.74+/-1.30, P < 0.05) and total volume of distribution (26.55+/-4.80 liter/m(2), nl 13.10+/-2.54, P < 0.01). However, the unaltered Kii suggested an extravascular binding impairment comparable to that found in serum. The decreased T(3) production rate (6.34+/-0.53 mug/d per m(2), nl 23.47+/-2.12, P < 0.005) appeared to result from reduced peripheral T(4) to T(3) conversion because of decreased 5'-deiodination rather than from a decreased T(4) availability. This view was supported by the normality of the rT(3) production rate. The normal Kii values for rT(3) indicated a comparable defect in serum and extravascular rT(3) binding. The reduced MCR (25.05+/-6.03 liter/d per m(2), nl 59.96+/-8.56, P < 0.005) and FCR (191.0+/-41.19%, nl 628.0+/-199.0, P < 0.02) for rT(3) are compatible with an impairment of the rT(3) deiodination rate. These alterations in thyroid hormones indices and kinetic parameters for T(4), T(3), and rT(3) in the low T(4) state of acute nonthyroidal illnesses can be accounted for by: (a) decreased binding of T(4), T(3), and rT(3) to vascular and extravascular sites with a proportionately greater impairment of extravascular T(4) binding, and (b) impaired 5'-deiodination activity affecting both T(4) and rT(3) metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801090      PMCID: PMC371008          DOI: 10.1172/jci110478

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Suprahypophyseal hypogonadism and hypothyroidism during prolonged coma after head trauma.

Authors:  D Rudman; A S Fleischer; M H Kutner; J F Raggio
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

2.  In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses.

Authors:  I J Chopra; G N Teco; A H Nguyen; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

3.  The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Free thyroxine in serum as estimated by polyacrylamide gel filtration.

Authors:  L J McDonald; N I Robin; L Siegel
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

5.  Corticosteroids and thyroid function. Different effects on plasma volume, thyroid hormones and thyroid hormone-binding proteins after oral and intravenous administration.

Authors:  A Gamstedt; G Järnerot; B Kågedal; B Söderholm
Journal:  Acta Med Scand       Date:  1979

6.  Preparation, purification, and stability of high specific activity 125I-labeled thyronines.

Authors:  N Kochupillai; R S Yalow
Journal:  Endocrinology       Date:  1978-01       Impact factor: 4.736

7.  Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography.

Authors:  S Y Wu; I J Chopra; D H Solomon; L R Bennett
Journal:  J Clin Endocrinol Metab       Date:  1978-04       Impact factor: 5.958

8.  Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses.

Authors:  I J Chopra; D H Solomon; G W Hepner; A A Morgenstein
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

9.  Evaluation of triiodothyronine (T3) kinetics in normal subjects, in hypothyroid, and hyperthyroid patients using specific antiserum for the determination of labeled T3 in plasma.

Authors:  R Bianchi; G C Zucchelli; D Giannessi; A Pilo; G Mariani; A Carpi; M G Toni
Journal:  J Clin Endocrinol Metab       Date:  1978-02       Impact factor: 5.958

10.  Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver.

Authors:  A S Jennings; D C Ferguson; R D Utiger
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

View more
  26 in total

1.  A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome.

Authors:  T Nagaya; M Fujieda; G Otsuka; J P Yang; T Okamoto; H Seo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Serum cortisol and thyroid hormone levels in neonates with sepsis.

Authors:  B K Das; Pooja Agarwal; J K Agarwal; O P Mishra
Journal:  Indian J Pediatr       Date:  2002-08       Impact factor: 1.967

3.  N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial.

Authors:  Josi Vidart; Simone Magagnin Wajner; Rogério Sarmento Leite; André Manica; Beatriz D Schaan; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

4.  Plasma membrane transport of thyroid hormone: its possible pathophysiological significance.

Authors:  E P Krenning; R Docter; T J Visser; G Hennemann
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

5.  Thyroid disease in the elderly--missed diagnosis or overdiagnosis?

Authors:  M J Rosenthal; C J Sanchez
Journal:  West J Med       Date:  1985-11

6.  Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Authors:  N A Salomon-Montavon; A G Burger
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Studies on the possible role of thyroid hormone in altered muscle protein turnover during sepsis.

Authors:  P O Hasselgren; I W Chen; J H James; M Sperling; B W Warner; J E Fischer
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

Review 8.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

9.  Evaluation of serum total thyroxine and triiodothyronine and their serum fractions in nonthyroidal illness secondary to congenital heart disease. Studies before and after surgery.

Authors:  A Belgorosky; G Weller; E Chaler; S Iorcansky; M A Rivarola
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

10.  Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.

Authors:  S M Lum; J T Nicoloff; C A Spencer; E M Kaptein
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.